Mayo Clinic: Sepsis trials

The registry lists 16 Sepsis studies with Mayo Clinic as lead sponsor. 2 are open to participants now and 1 have results posted.

Phase 1 3Phase 2 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• BLOOM: Pragmatic Feasibility TrialRecruitingNCT07287332Not applicable
• MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) TrialRecruitingNCT06319248Phase 2
• Rapid Identification and Susceptibility Testing of Pathogens From Blood CulturesCompletedNCT01898208Not applicableResults posted
• Dialysis Catheter Caps Case Feasibility StudyActive, not recruitingNCT06905080Not applicable
• Dynamics of Organ Damage and Immune Exhaustion During SepsisActive, not recruitingNCT06817408
• Provider Perspectives on Beta-lactam Therapeutic Drug Monitoring Programs in the Critically IllCompletedNCT04755777
• Midodrine Hydrochloride in Early SepsisCompletedNCT03129542Phase 1
• Cystatin-C C-guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement ProjectCompletedNCT02945241Phase 1
• Clinical Score Usefulness and EHR IntegrationCompletedNCT02755025
• Implementation of a Web Based Real Time Clinical Decision Support Tool.CompletedNCT02398981Not applicable
• Patient Centered Cloud-based Electronic System: Ambient Warning and Response Evaluation (ProCCESs AWARE)CompletedNCT02039297Not applicable
• The Checklist for Early Recognition and Treatment of Acute Illness (CERTAIN)CompletedNCT01973829Not applicable
• Timing and Intensity of the Exposures and Attributable Burden of Acute Lung InjuryCompletedNCT00980915
• Lung Injury Prediction StudyCompletedNCT00889772
• A Simple Clinical Tool to Help Assess Patient Volume (Fluid) StatusCompletedNCT00599794
• The Effects of HIV Protease Inhibitors in Severe SepsisCompletedNCT00346580Phase 1